The enriched KEGG pathways were as follows: “cytokine–cytokine receptor interaction”, “chemokine signaling pathway”, “intestinal immune network for IgA production”, and “inflammatory bowel disease”, indicating the potential role of CCL22 in gastrointestinal diseases (Figure 4B). The gene discussed is CCL22; the disease is inflammatory bowel disease.